Arete Wealth Advisors’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-9,485
Closed -$778K 471
2025
Q4
$778K Sell
9,485
-300
-3% -$23.4K 0.05% 331
2025
Q3
$735K Buy
9,785
+173
+2% +$12.9K 0.05% 347
2025
Q2
$712K Sell
9,612
-176
-2% -$12.3K 0.05% 318
2025
Q1
$790K Sell
9,788
-107
-1% -$9.2K 0.06% 284
2024
Q4
$774K Sell
9,895
-3
-0% -$255 0.06% 305
2024
Q3
$924K Sell
9,898
-605
-6% -$50.8K 0.08% 234
2024
Q2
$814K Buy
10,503
+40
+0.4% +$3.26K 0.07% 278
2024
Q1
$951K Sell
10,463
-86
-0.8% -$7.16K 0.09% 217
2023
Q4
$816K Buy
10,549
+40
+0.4% +$2.8K 0.06% 294
2023
Q3
$715K Buy
10,509
+2,677
+34% +$195K 0.12% 182
2023
Q2
$636K Buy
7,832
+3,598
+85% +$287K 0.06% 314
2023
Q1
$347K Buy
+4,234
New +$302K 0.03% 435

Other funds holding GEHC

Arete Wealth Advisors's GEHC Position: Q1 2026 in Review

Arete Wealth Advisors sold out of GE HealthCare (GEHC) in Q1 2026, closing a stake of 9,485 shares — an estimated $778K sold.

Arete Wealth Advisors first reported a position in GEHC in Q1 2023 and held it in 12 quarters. The position peaked at $951K in Q1 2024. 1,263 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Arete Wealth Advisors reported no remaining GE HealthCare position as of Q1 2026 after selling out during the quarter.
  • Arete Wealth Advisors sold 9,485 GE HealthCare shares in Q1 2026, an estimated $778K.
  • Arete Wealth Advisors first reported a position in GE HealthCare in Q1 2023 and held it in 12 quarters.
  • Arete Wealth Advisors's GE HealthCare position peaked at $951K in Q1 2024.
  • 1,263 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Arete Wealth Advisors's 13F filing for Q1 2026, filed 18 May 2026.